You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 13, 2025

Drug Price Trends for DEPO-PROVERA


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DEPO-PROVERA

Average Pharmacy Cost for DEPO-PROVERA

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
DEPO-PROVERA 150 MG/ML VIAL 00009-0746-30 50.54200 ML 2025-03-19
DEPO-PROVERA 150 MG/ML SYRINGE 00009-7376-11 53.02100 ML 2025-03-19
DEPO-PROVERA 150 MG/ML VIAL 00009-0746-30 50.54200 ML 2025-02-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 3 of 3 entries

Market Analysis and Price Projections for Depo-Provera

Introduction to Depo-Provera

Depo-Provera, also known as medroxyprogesterone acetate, is a widely used injectable contraceptive that has been a staple in reproductive health for decades. It is administered via intramuscular injection every three months and is known for its high efficacy in preventing pregnancy.

Market Dominance and Share

Depo-Provera holds a significant market share in the global injectable contraceptives market. By 2021, it controlled approximately 60% of the global phase III progesterone-only injectable contraceptives market, making it a leading player in this segment[4].

Market Drivers

Several factors drive the demand for Depo-Provera and other injectable contraceptives:

Increasing Awareness and Education

There is a growing awareness about the benefits of injectable contraceptives, particularly among women who seek effective and convenient methods of pregnancy prevention. This increased knowledge has contributed to the expansion of the market[4].

High Efficacy

Depo-Provera is highly effective, with a failure rate of only about 4% per year, making it a reliable choice for those seeking to prevent pregnancy. This high efficacy rate is a major driver for its popularity[4].

Convenience

The need for injections only every three months makes Depo-Provera more flexible and less burdensome than daily oral contraceptives. This convenience is a significant factor in its market appeal[4].

Demographic Analysis

Age Groups

The market for Depo-Provera is segmented across various age groups, with the highest demand typically coming from women aged 15-34 years. This demographic is particularly attracted to the convenience and efficacy of injectable contraceptives[4].

Geographic Distribution

The market is also segmented geographically, with North America being a significant region. However, the demand for Depo-Provera is global, reflecting the universal need for effective contraceptive methods[4].

Cost and Pricing

Current Pricing

The cost of Depo-Provera can vary depending on the region and pharmacy. In the United States, the price for a 1 milliliter supply of Depo-Provera intramuscular suspension is around $65 for cash-paying customers. Generic versions are available at a lower cost, starting from around $35 for 1 milliliter[2].

International Pricing

In other regions, such as India, the price for a pre-filled syringe of Depo-Provera can be significantly lower, around ₹286.75 (approximately $3.50 USD), reflecting local market dynamics and pricing strategies[3].

Cost-Benefit Analysis

A cost-benefit analysis of hormonal contraceptive methods, including Depo-Provera, has shown that Depo-Provera has the highest net benefit among the methods analyzed. This is due to its high efficacy, long-lasting protection, and the convenience of fewer administrations compared to other methods[5].

Price Projections

Market Trends

The injectable contraceptives market, driven by the increasing demand for effective and convenient pregnancy prevention methods, is expected to grow. The market share of Depo-Provera is likely to remain strong due to its established reputation and high efficacy[4].

Economic Factors

Economic factors such as the availability of generic versions and discount programs can influence pricing. For instance, the use of discount cards can reduce the cost of Depo-Provera by up to 80% in some cases[2].

Future Pricing

Given the growing demand and the competitive landscape, prices for Depo-Provera are likely to remain stable or see moderate increases. The availability of generic options will continue to provide affordable alternatives, keeping prices in check.

Competitive Landscape

The market for injectable contraceptives is dominated by Depo-Provera, but other products like norethisterone enanthate also exist. The competitive landscape is influenced by the introduction of new products and the expansion of existing ones into new markets[4].

Regulatory and Health Considerations

Safety and Efficacy

Depo-Provera has been associated with some health risks, such as an increased relative risk of breast cancer in women under 35 years old who were first exposed to the drug within the previous four years. However, the overall relative risk for ever-users is not significantly elevated[1].

Regulatory Approvals

Depo-Provera has been approved by regulatory bodies such as the FDA and is widely available in many countries. Regulatory approvals and guidelines play a crucial role in the market dynamics of pharmaceutical products.

Key Takeaways

  • Market Dominance: Depo-Provera controls a significant share of the global injectable contraceptives market.
  • High Efficacy: It has a failure rate of about 4% per year, making it highly effective.
  • Convenience: Injections are required only every three months, making it more convenient than daily oral contraceptives.
  • Cost: Prices vary globally, with generic versions available at lower costs.
  • Cost-Benefit Analysis: Depo-Provera has the highest net benefit among analyzed hormonal contraceptive methods.
  • Future Projections: Prices are likely to remain stable or see moderate increases due to growing demand and competitive market dynamics.

FAQs

What is the primary advantage of using Depo-Provera?

The primary advantage of using Depo-Provera is its high efficacy in preventing pregnancy, with a failure rate of only about 4% per year, and the convenience of requiring injections only every three months.

How much does Depo-Provera cost?

The cost of Depo-Provera can vary, but in the United States, it is around $65 for a 1 milliliter supply for cash-paying customers. Generic versions are available at a lower cost, starting from around $35.

Is Depo-Provera associated with any health risks?

Yes, Depo-Provera has been associated with an increased relative risk of breast cancer in women under 35 years old who were first exposed to the drug within the previous four years. However, the overall relative risk for ever-users is not significantly elevated.

What is the market share of Depo-Provera in the global injectable contraceptives market?

By 2021, Depo-Provera controlled approximately 60% of the global phase III progesterone-only injectable contraceptives market.

Are there any discount programs available for Depo-Provera?

Yes, there are discount programs and cards available that can reduce the cost of Depo-Provera by up to 80%.

How does the cost of Depo-Provera compare internationally?

The cost of Depo-Provera can be significantly lower in some regions, such as India, where it can cost around ₹286.75 (approximately $3.50 USD) for a pre-filled syringe.

Sources

  1. FDA Label: Depo-Provera Contraceptive Injection Label[1].
  2. Drugs.com: Depo Provera Prices, Coupons, Copay Cards & Patient Assistance[2].
  3. PharmEasy: Depo Provera 150mg Pre Filled Syringe Of 1ml Injection[3].
  4. Stellar Market Research: Injectable Contraceptives Market - Industry Analysis and Forecast[4].
  5. PubMed: A cost-benefit analysis of four hormonal contraceptive methods[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.